Showing 6941-6950 of 23151 results for "".
Twitter, Linked-In and Facebook: How NPs can Benefit From Social Media
https://reachmd.com/programs/partners-in-practice/twitter-linked-in-and-facebook-how-nps-can-benefit-from-social-media/5927/Millions of people worldwide have Facebook, LinkedIn and Twitter accounts. What do you need to know about today's Internet-savvy e-Patient, who uses online tools to share information with their medical providers, search for medical information, and manage and cope with their medical conditions. NursIs the Future of the Physician-Scientist in Danger?
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/is-the-future-of-the-physician-scientist-in-danger/5467/Though practicing clinicians have long played an important role in medical research and advancing medical treatments, their position in the laboratory has changed dramatically in recent years. But is the future of the physician-scientist in danger? Dr. Andrew Schafer, chairman of the department of mDispatches From the Haiti Earthquake Relief
https://reachmd.com/programs/neurofrontiers/dispatches-from-the-haiti-earthquake-relief/5327/Host Dr. Anthony Alessi interviews neurologist Lt. Cmdr. Mill Etienne, MD, at St. Damien's Pediatric Hospital in Port-au-Prince, Hati. Dr. Etienne is a Hatian-American physician in the United States military, stationed on the USNS Comfort. They discuss Dr. Etienne's work providing medical care, in aUpdate From Haiti: The Next Phase of the Medical Response
https://reachmd.com/programs/second-opinion-live/update-from-haiti-the-next-phase-of-the-medical-response/5230/Several weeks after the devastating earthquake in Haiti, we revisit the medical response with three physicians, all with different specialties and all with a deep connection to Haiti. Hosts Dr. Matt Birnholz and Dr. Michael Greenberg speak with Dr. Anthony Alessi, host of ReachMD's NeuroFrontiers anThe Future of Proton Therapy
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/the-future-of-proton-therapy/4768/Proton therapy has existed for decades, but it's only recently begun to be clinically adopted. Rather than being a stand-alone treatment, this therapy is often best used in conjunction with surgery or chemotherapy. Outside of oncology, what other conditions might proton therapy be used to treat? JoiToward Safe and Effective Insulin Initiation
https://reachmd.com/programs/diabetes-discourse/toward-safe-and-effective-insulin-initiation/4579/Type 2 diabetes is a progressive disease and most patients will eventually need insulin to achieve euglycemia. Early and aggressive management to lower blood glucose reduces the risk of complications of the disease. It can be challenging for health care professionals to decide which treatment regimeA Vaccine to Reduce Congenital CMV and Sequelae
https://reachmd.com/programs/focus-on-allergy/a-vaccine-to-reduce-congenital-cmv-and-sequelae/4419/Congenital cytomegalovirus (CMV) infection causes auditory, cognitive and neurologic impairment in thousands of infants each year in the United States. Recognition of infection in pregnant women is difficult because CMV often produces few symptoms, and antiviral treatment during pregnancy may have tPromising New Biomarker to Predict Colorectal Cancer Recurrence
https://reachmd.com/programs/focus-on-cancer/promising-new-biomarker-to-predict-colorectal-cancer-recurrence/4324/How is the biomarker guanylyl cyclase 2C helping to predict colorectal cancer recurrence rates? Host Dr. Lee Freedman welcomes Dr. Scott Waldman, professor in the departments of medicine and biochemistry at Thomas Jefferson University, to discuss how this biomarker found in regional lymph nodes canNatural History of Breast Cancer: Early Detection vs. Mortality
https://reachmd.com/programs/focus-on-cancer/natural-history-of-breast-cancer-early-detection-vs-mortality/4319/The widespread use of mammography to screen for breast cancer has resulted in a decrease in breast tumor detection, as well as decrease in mortality rates associated with the disease. But the natural course of malignant diseases such as different types of cancer can vary considerably. Is it possibleSurgical Care in Global Health Settings
https://reachmd.com/programs/focus-on-global-medicine/surgical-care-in-global-health-settings/4279/Little is known currently about the amount and availability of surgical care worldwide. How does this challenge development of surgical care protocols globally and, by extension, the formation of international public health policies? Dr. Alex Haynes, surgical research fellow at the Harvard School of